Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroDerm Ltd NDRM

Healthcare Biotechnology
"NeuroDerm Ltd is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system diseases, including Parkinson's disease as well as other CNS diseases."

Recent & Breaking News (NDAQ:NDRM)

NeuroDerm Announces Removal of FDA Import Alert of Infusion Pumps Used in ND0612 Clinical Trials

GlobeNewswire April 22, 2016

NeuroDerm Parkinson's Disease Clinical Data Selected for Two Oral Presentations at the American Academy of Neurology 68th Annual Meeting

GlobeNewswire April 5, 2016

NeuroDerm Announces Fourth Quarter and Full Year 2015 Financial Results and Provides a Corporate Update

GlobeNewswire March 31, 2016

NeuroDerm to Host Fourth Quarter and 2015 Fiscal Year Financial Results Conference Call on March 31, 2016

GlobeNewswire March 22, 2016

NeuroDerm to Present at Upcoming Investor Conferences

GlobeNewswire March 2, 2016

Holding the Course, Oculus Innovative Sciences Delivers Revenue Growth Again

Accesswire February 9, 2016

NeuroDerm CEO to Present at the 34th Annual J.P. Morgan  Healthcare Conference on January 14, 2016

GlobeNewswire January 4, 2016

NeuroDerm Announces Start of Patient Enrollment in Phase II Trial of ND0612H for Advanced Parkinson's Disease

GlobeNewswire December 30, 2015

NeuroDerm Added to the Nasdaq Biotechnology Index

GlobeNewswire December 18, 2015

Analyst Insights Behind Price Movement - Research on Ashford Hospitality Prime, Neuroderm, NN, and Roadrunner Transportation Systems

Accesswire November 25, 2015

Where Opportunity is Found - Research on Ashford Hospitality Prime, NEURODERM, NN Inc. and Roadrunner Transportation Systems

Accesswire November 17, 2015

NeuroDerm CEO to Present at Upcoming Investor Conferences

GlobeNewswire November 12, 2015

NeuroDerm Announces Third Quarter 2015 Financial Results

GlobeNewswire November 11, 2015

NeuroDerm Announces Streamlined U.S. Development Plan Following FDA Feedback on ND0612H and ND0612L for the Treatment of Parkinson's Disease

GlobeNewswire November 11, 2015

What Makes a Chart Move? Technical Review of K12, Ashford Hospitality Prime, NEURODERM and NN Inc.

Accesswire November 10, 2015

NeuroDerm to Host Third Quarter 2015 Financial Results Conference Call on November 11, 2015

GlobeNewswire November 4, 2015

NeuroDerm Announces 2015 Annual General Meeting of Shareholders

GlobeNewswire September 24, 2015

NeuroDerm Announces Second Quarter 2015 Financial Results and Provides Corporate Update

GlobeNewswire August 6, 2015

NeuroDerm to Host Second Quarter 2015 Financial Results Conference Call on August 6, 2015

GlobeNewswire July 30, 2015

NeuroDerm Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire July 21, 2015